Literature DB >> 32078089

Pediatric Anxiety Disorders: A Cost of Illness Analysis.

Jeffrey E Pella1, Eric P Slade2, Paige J Pikulski3, Golda S Ginsburg3.   

Abstract

Few studies provide information about the clinical correlates of economic costs in pediatric anxiety disorders. This study uses baseline data from a randomized trial involving 209 children and adolescents with clinical anxiety to examine clinical and demographic correlates of direct and indirect costs. Measured costs included the direct costs of mental health services and the indirect costs resulting from children's missed school and parents' missed work. Validated measures of anxiety and depression severity and of internalizing and externalizing behaviors were reported by youth, their parents, and independent evaluators. Seventy-two percent of youth (n = 150) had positive costs. Among these youth, the mean annual total cost was $6405 (sd = $11,674), of which $5890 represented direct cost and $4658 represented indirect cost. Higher average costs were correlated with greater child anxiety and depression severity (p < 0.001). Most pediatric anxiety disorders result in substantial individual and family costs, and costs may increase rapidly with elevated anxiety severity and depressed mood.

Entities:  

Keywords:  Anxiety disorders; Cost-of-illness; Pediatric anxiety; Predictors of cost

Mesh:

Year:  2020        PMID: 32078089     DOI: 10.1007/s10802-020-00626-7

Source DB:  PubMed          Journal:  J Abnorm Child Psychol        ISSN: 0091-0627


  15 in total

1.  DSM-oriented and empirically based approaches to constructing scales from the same item pools.

Authors:  Thomas M Achenbach; Levent Dumenci; Leslie A Rescorla
Journal:  J Clin Child Adolesc Psychol       Date:  2003-09

2.  Testing the odds of inherent vs. observed overdispersion in neural spike counts.

Authors:  Wahiba Taouali; Giacomo Benvenuti; Pascal Wallisch; Frédéric Chavane; Laurent U Perrinet
Journal:  J Neurophysiol       Date:  2015-10-07       Impact factor: 2.714

3.  School-Based Treatment for Anxiety Research Study (STARS): a Randomized Controlled Effectiveness Trial.

Authors:  Golda S Ginsburg; Jeffrey E Pella; Paige J Pikulski; Jenn-Yun Tein; Kelly L Drake
Journal:  J Abnorm Child Psychol       Date:  2020-03

4.  Psychometric properties of the Revised Child Anxiety and Depression Scale in a clinical sample.

Authors:  Bruce F Chorpita; Catherine E Moffitt; Jennifer Gray
Journal:  Behav Res Ther       Date:  2005-03

5.  Test-retest reliability of anxiety symptoms and diagnoses with the Anxiety Disorders Interview Schedule for DSM-IV: child and parent versions.

Authors:  W K Silverman; L M Saavedra; A A Pina
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2001-08       Impact factor: 8.829

6.  Service utilization for lifetime mental disorders in U.S. adolescents: results of the National Comorbidity Survey-Adolescent Supplement (NCS-A).

Authors:  Kathleen Ries Merikangas; Jian-ping He; Marcy Burstein; Joel Swendsen; Shelli Avenevoli; Brady Case; Katholiki Georgiades; Leanne Heaton; Sonja Swanson; Mark Olfson
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2010-12-03       Impact factor: 8.829

7.  Lifetime prevalence of mental disorders in U.S. adolescents: results from the National Comorbidity Survey Replication--Adolescent Supplement (NCS-A).

Authors:  Kathleen Ries Merikangas; Jian-Ping He; Marcy Burstein; Sonja A Swanson; Shelli Avenevoli; Lihong Cui; Corina Benjet; Katholiki Georgiades; Joel Swendsen
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2010-07-31       Impact factor: 8.829

8.  A cost of illness study of children with high-functioning autism spectrum disorders and comorbid anxiety disorders as compared to clinically anxious and typically developing children.

Authors:  Francisca J A van Steensel; Carmen D Dirksen; Susan M Bögels
Journal:  J Autism Dev Disord       Date:  2013-12

9.  Attention-deficit/hyperactivity disorder: increased costs for patients and their families.

Authors:  Andrine R Swensen; Howard G Birnbaum; Kristina Secnik; Maryna Marynchenko; Paul Greenberg; Ami Claxton
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2003-12       Impact factor: 8.829

10.  Societal burden of clinically anxious youth referred for treatment: a cost-of-illness study.

Authors:  Denise H M Bodden; Carmen D Dirksen; Susan M Bögels
Journal:  J Abnorm Child Psychol       Date:  2008-01-23
View more
  6 in total

Review 1.  Evidence for investing in parenting interventions aiming to improve child health: a systematic review of economic evaluations.

Authors:  Filipa Sampaio; Camilla Nystrand; Inna Feldman; Cathrine Mihalopoulos
Journal:  Eur Child Adolesc Psychiatry       Date:  2022-03-19       Impact factor: 4.785

2.  Harnessing Home-School Partnerships and School Consultation to Support Youth With Anxiety.

Authors:  Kristina Conroy; Natalie Hong; Bridget Poznanski; Katie C Hart; Golda S Ginsburg; Gregory A Fabiano; Jonathan S Comer
Journal:  Cogn Behav Pract       Date:  2021-04-21

3.  Client-rated facilitators and barriers to long-term youth anxiety disorder recovery.

Authors:  Elizabeth P Casline; Robert R Ogle; Tara S Peris; Philip C Kendall; John Piacentini; Scott N Compton; Courtney Keeton; Golda S Ginsburg
Journal:  J Clin Psychol       Date:  2022-06-10

4.  A Scoping Review of Associations Between Cannabis Use and Anxiety in Adolescents and Young Adults.

Authors:  Colleen Stiles-Shields; Joseph Archer; Jim Zhang; Amanda Burnside; Janel Draxler; Lauren M Potthoff; Karen M Reyes; Faith Summersett Williams; Jennifer Westrick; Niranjan S Karnik
Journal:  Child Psychiatry Hum Dev       Date:  2021-11-01

5.  Current anxiety problems and organized activity participation among U.S. adolescents.

Authors:  Kayleigh A Gregory; Rebecca A Vidourek; Keith A King; Ashley L Merianos
Journal:  Curr Psychol       Date:  2022-09-30

6.  Cost-Benefit Analysis of an Intervention in Divorced Parents: Implications for Society, Public Administrations and Family Visitation Centers.

Authors:  Leire Alcaniz; Ana Martínez-Pampliega; Marta Herrero
Journal:  Int J Environ Res Public Health       Date:  2022-03-15       Impact factor: 3.390

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.